TP53 and breast cancer: In a BRCA-based breast cancer series (Series 2, n = 202), which was enriched for cases with germline BRCA1 or BRCA2 mutations, strong associations with high histologic grade, tumor cell proliferation (by mitotic count), and p53 expression were present (Supplementary Table 1).